Skip to main content
logo
NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
29.64
-0.91 (-2.98%)
At close: Jul 24, 2026, 4:00 PM EDT
30.09
+0.45 (1.52%)
After-hours: Jul 24, 2026, 7:58 PM EDT

NAMS Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
22.5722.545.5614.09102.69-
Revenue Growth
-52.13%-50.61%223.37%-86.28%--
Gross Profit
22.5722.545.5614.09102.69-
Operating Income
-216.87-227.37-180.44-182.97-70.94-33.93
Net Income
-214.45-205.53-245.78-176.94-82-32.52
Earnings Per Share
-1.81-1.74-2.60-2.15-1.19-1.38
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
636.11636.24834.19340.45467.7360.37
Total Debt
0.020.20.450.060.130.19
Net Cash (Debt)
636.08636.04833.74340.39467.660.19
Net Cash Growth
-21.29%-23.71%144.94%-27.21%676.92%-
Net Cash Per Share
5.315.378.844.1424.652.55

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-141.92-143.02-158.81-141.227.03-28.62
Capital Expenditures
-0.27-0.25-0.25-0.02-0.01-0.02
Free Cash Flow
-142.19-143.26-159.05-141.247.02-28.64
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-961.09%-1010.42%-396.02%-1298.56%-69.08%-
Pretax Margin
-950.36%-913.36%-539.42%-1255.57%-79.85%-
Profit Margin
-950.36%-913.36%-539.42%-1255.76%-79.85%-
FCF Margin
-630.12%-636.63%-349.08%-1002.43%6.83%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
----126.66-
PS Ratio
153.56178.3460.9565.388.66-